Citations: Giavedoni,L.D.. Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. Journal of Immunological Methods 2005;301:89-101. (Link)
Chudyk,A.; Masiuk,M.; Myslak,M.; Domanski,L.; Sienko,J.; Sulikowski,T.; Machalinski,B.; Giedrys-Kalemba,S.. Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition. Transplantation Proceedings 2006;38:90-93. (Link)
Rimoldi,Monica; Chieppa,Marcello; Salucci,Valentina; Avogadri,Francesca; Sonzogni,Angelica; Sampietro,Gianluca; Nespoli,Angelo; Viale,Giuseppe; Allavena,Paola; Rescigno,Maria. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-514. (Link)
Schmidt J,Welsch T,J„ger D,Mhlradt PF,Bchler MW,M„rten A.. Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.. British Journal of Cancer 2007;97:598-604. (Link)
Veckman,V.; Julkunen,I.. Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells. J Leukoc.Biol 2008;83:296-304. (Link)
Kozma,Noemi; Halasz,Melinda; Polgar,Beata; Poehlmann,Tobias G.; Markert,Udo R.; Palkovics,Tamas; Keszei,Marton; Par,Gabriella; Kiss,Katalin; Szeberenyi,Jozsef; Grama,Laszlo; Szekeres-Bartho,Julia. Progesterone-Induced Blocking Factor Activates STAT6 via Binding to a Novel IL-4 Receptor. The Journal of Immunology 2006;176:819-826. (Link)
Catellani S,Poggi A,Bruzzone A,Dadati P,Ravetti JL,Gobbi M,Zocchi MR.. Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins. Blood 2007;109:2078-2085. (Link)
Raveney,B.J.; Richards,C.M.; Aknin,M.L.; Copland,D.A.; Burton,B.R.; Kerr,E.C.; Nicholson,L.B.; Williams,N.A.; Dick,A.D.. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established autoimmune uveoretinitis. Invest Ophthalmol.Vis.Sci. 2008;49:4008-4017. (Link)
Bonelli,Michael; Savitskaya,Anastasia; STEINER,CARL WALTER; Rath,Eva; Smolen,Josef S.; Scheinecker,Clemens. Phenotypic and Functional Analysis of CD4+CD25-Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus. The Journal of Immunology 2009;182:1689-1695. (Link)
Quiroga,Juan A.; Llorente,Silvia; Castillo,Inmaculada; Rodriguez-Inigo,Elena; Pardo,Margarita; Carreno,Vicente. Cellular Immune Responses Associated with Occult Hepatitis C Virus Infection of the Liver. Journal of Virology 2006;80:10972-10979. (Link)
Yu,Tung Min; Chen,Yi Hsing; Hsu,Jeng Yuan; Sun,Chung Shu; Chuang,Ya Wen; Chen,Cheng Hsu; Wu,Ming Ju; Cheng,Chi Hung; Shu,Kuo Hsiung. Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis. Nephrology Dialysis Transplantation 2009;24:1946-1951. (Link)
Below,Sabine; Konkel,Anne; Zeeck,Cathrin; Muller,Christian; Kohler,Christian; Engelmann,Susanne; Hildebrandt,Jan Peter. Virulence factors of Staphylococcus aureus induce Erk-MAP kinase activation and c-Fos expression in S9 and 16HBE14o- human airway epithelial cells. Lung Cellular and Molecular Physiology 2009;296:L470-L479. (Link)
Makela,Sanna M.; Strengell,Mari; Pietila,Taija E.; Osterlund,Pamela; Julkunen,Ilkka. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. Journal of Leukocyte Biology 2009;85:664-672. (Link)
Schmidt J,J„ger D,Hoffmann K,Bchler MW,M„rten A.. Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring. J Immunother. 2007;30:108-115. (Link)
Lirussi,Frederic; Rakotoniaina,Zo; Madani,Siham; Goirand,Francoise; Breuiller-Fouche,Michelle; Leroy,Marie Josephe; Sagot,Paul; Morrison,John J.; Dumas,Monique; Bardou,Marc. ADRB3 Adrenergic Receptor Is a Key Regulator of Human Myometrial Apoptosis and Inflammation During Chorioamnionitis. Biology of Reproduction 2008;78:497-505. (Link)
Braudeau,C.; Racape,M.; Giral,M.; Louis,S.; Moreau,A.; Berthelot,L.; Heslan,M.; shton-Chess,J.; Soulillou,J.P.; Brouard,S.. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl.Int 2007;20:845-855. (Link)
Munitz,Ariel; Bachelet,Ido; Eliashar,Ron; Moretta,Alessandro; Moretta,Lorenzo; Levi-Schaffer,Francesca. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006;107:1996-2003. (Link)
Siebert,J.C.; Inokuma,M.; Waid,D.M.; Pennock,N.D.; Vaitaitis,G.M.; Disis,M.L.; Dunne,J.F.; Wagner,D.H.,Jr.; Maecker,H.T.. An analytical workflow for investigating cytokine profiles. Cytometry A 2008;73:289-298. (Link)
Tomchuck,Suzanne L.; Zwezdaryk,Kevin J.; Coffelt,Seth B.; Waterman,Ruth S.; Danka,Elizabeth S.; Scandurro,Aline B.. Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses. Stem Cells 2008;26:99-107. (Link)
Eixarch,Herena; Espejo,Carmen; Gomez,Alba; Mansilla,Maria Jose; Castillo,Mireia; Mildner,Alexander; Vidal,Francisco; Gimeno,Ramon; Prinz,Marco; Montalban,Xavier; Barquinero,Jordi. Tolerance Induction in Experimental Autoimmune Encephalomyelitis Using Non-myeloablative Hematopoietic Gene Therapy With Autoantigen. Mol Ther 2009;17:897-905. (Link)
Kauss,Tina; Moynet,Daniel; Rambert,J; Al-Kharrat,Abir; Brajot,Stephane; Thiolat,Denis; Ennemany,Rachid; Fawaz,Fawaz;. Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis. Arthritis Research & Therapy 2008;10:R19(Link)
Elamin,R.D.ZeŠevi‘,D.Vojvodi‘,L.Medenica,and M.D.Pavlovi‘. Cytokine concentrations in basal cell carcinomas of different histological types and localization. Acta Dermatoven APA 2008;17:55-59. (Link)
Van Gulck,Ellen R.; Vanham,Guido; Heyndrickx,Leo; Coppens,Sandra; Vereecken,Katleen; Atkinson,Derek; Florence,Eric; Kint,Ilse; Berneman,Zwi Nisan; Tendeloo,Viggo Van. Efficient In Vitro Expansion of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses by gag mRNA-Electroporated Dendritic Cells from Treated and Untreated HIV Type 1-Infected Individuals. Journal of Virology 2008;82:3561-3573. (Link)
Bermejo-Martin,J.F.; Bernardo,D.; Dominguez-Gil,M.; Alonso,A.; Garcia-Arevalo,M.C.; Pino,M.; de Lejarazu,R.O.; Eiros,J.M.; Ardura,J.; Leon,A.J.; Garrote,J.A.; Resino,S.; Blanco-Quiros,A.; Munoz-Fernandez,M.A.; Arranz,E.. Interleukin (IL)-1beta, IL-6 and IL-8 in nasal secretions: a common role for innate immunity in viral bronchial infection in infants?. Br J Biomed.Sci. 2006;63:173-175. (Link)
Rambert,Jerome; Mamani-Matsuda,Maria; Moynet,Daniel; Dubus,Pierre; Desplat,Vanessa; Kauss,Tina; Dehais,Jo; Schaeverbeke,Thierry; Ezzedine,Khaled; Malvy,Denis; Vincendeau,Philippe;. Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis. PLoS ONE 2009;4:(Link)
References: Kawane,K.; Ohtani,M.; Miwa,K.; Kizawa,T.; Kanbara,Y.; Yoshioka,Y.; Yoshikawa,H.; Nagata,S.. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 2006;443:998-1002. (Link)
Van Zee,K.J.; Kohno,T.; Fischer,E.; Rock,C.S.; Moldawer,L.L.; Lowry,S.F.. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc.Natl.Acad.Sci.U.S.A 1992;89:4845-4849. (Link)
Aggarwal,B.B.; Shishodia,S.; Takada,Y.; Jackson-Bernitsas,D.; Ahn,K.S.; Sethi,G.; Ichikawa,H.. TNF blockade: an inflammatory issue. Ernst.Schering.Res Found.Workshop 2006;161-186. (Link)
Digel,W.; Porzsolt,F.; Schmid,M.; Herrmann,F.; Lesslauer,W.; Brockhaus,M.. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J.Clin.Invest 1992;89:1690-1693. (Link)
Pfeffer,K.. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14:185-191. (Link)
Scuderi,P.; Sterling,K.E.; Lam,K.S.; Finley,P.R.; Ryan,K.J.; Ray,C.G.; Petersen,E.; Slymen,D.J.; Salmon,S.E.. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 1986;2:1364-1365. (Link)
McGuire,W.; Hill,A.V.; Allsopp,C.E.; Greenwood,B.M.; Kwiatkowski,D.. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-510. (Link)
Moehle,C.; Ackermann,N.; Langmann,T.; Aslanidis,C.; Kel,A.; Kel-Margoulis,O.; Schmitz-Madry,A.; Zahn,A.; Stremmel,W.; Schmitz,G.. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 2006;84:1055-1066. (Link)
Adolf,G.R.; Apfler,I.. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids. J.Immunol.Methods 1991;143:127-136. (Link)
McLaughlin,P.J.; Aikawa,A.; Davies,H.M.; Ward,R.G.; Bakran,A.; Sells,R.A.; Johnson,P.M.. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 1991;51:1225-1229. (Link)
Aringer,M.; Smolen,J.S.. The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther 2008;10:202(Link)
Aderka,D.; Engelmann,H.; Maor,Y.; Brakebusch,C.; Wallach,D.. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J.Exp.Med. 1992;175:323-329. (Link)
Aggarwal,B.B.. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis 2000;59 Suppl 1:i6-16. (Link)
Firestein,G.S.; varo-Gracia,J.M.; Maki,R.. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J.Immunol. 1990;144:3347-3353. (Link)
Davis,J.C.,Jr.; Mease,P.J.. Insights into the pathology and treatment of spondyloarthritis: from the bench to the clinic. Semin.Arthritis Rheum 2008;38:83-100. (Link)
Al-Aly,Z.. Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl.Res 2008;151:233-239. (Link)
Holler,E.; Kolb,H.J.; Moller,A.; Kempeni,J.; Liesenfeld,S.; Pechumer,H.; Lehmacher,W.; Ruckdeschel,G.; Gleixner,B.; Riedner,C.; .. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75:1011-1016. (Link)
Mukhopadhyay,S.; Hoidal,J.R.; Mukherjee,T.K.. Role of TNFalpha in pulmonary pathophysiology. Respir.Res 2006;7:125(Link)
Lorenzo,M.; Fernandez-Veledo,S.; Vila-Bedmar,R.; Garcia-Guerra,L.; De,Alvaro C.; Nieto-Vazquez,I.. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci. 2008;86:E94-104. (Link)
Aggarwal,B.B.. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev.Immunol 2003;3:745-756. (Link)
Beutler,B.; Bazzoni,F.. TNF, apoptosis and autoimmunity: a common thread?. Blood Cells Mol Dis 1998;24:216-230. (Link)
Pietrzak,A.T.; Zalewska,A.; Chodorowska,G.; Krasowska,D.; Michalak-Stoma,A.; Nockowski,P.; Osemlak,P.; Paszkowski,T.; Rolinski,J.M.. Cytokines and anticytokines in psoriasis. Clin Chim.Acta 2008;394:7-21. (Link)
Wong,M.; Ziring,D.; Korin,Y.; Desai,S.; Kim,S.; Lin,J.; Gjertson,D.; Braun,J.; Reed,E.; Singh,R.R.. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol 2008;126:121-136. (Link)
Mocellin,S.; Rossi,C.R.; Pilati,P.; Nitti,D.. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev. 2005;16:35-53. (Link)
Lin,J.; Ziring,D.; Desai,S.; Kim,S.; Wong,M.; Korin,Y.; Braun,J.; Reed,E.; Gjertson,D.; Singh,R.R.. TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 2008;126:13-30. (Link)